Dr. Rehana Haque, MD

Dr. Haque practices at Long Island Jewish Medical Center in New Hyde Park, New York.

Dr. Haque's NPI, 1104041110, was assigned on April 16, 2007. Dr. Haque graduated from Sir Salimullah Medical College in 1992. Dr. Haque's New York license number on file is 239750.

Dr. Haque's primary practice is Long Island Jewish Medical Center, at 27005 76th Ave, New Hyde Park, NY 11040 in Nassau County. The practice phone is (516) 876-6000.

Dr. Haque's primary practice is Long Island Jewish Medical Center in New Hyde Park, New York. Dr. Haque is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haque practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Haque's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Haque is board certified in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dr. Haque has a license on file in New York.

Dmand AI lists anxiety, bipolar disorder, depression, insomnia, intellectual and developmental disabilities, non-alzheimer's dementia (chronic), schizophrenia and tobacco use among the conditions Dr. Haque treats.

CMS data shows 1,879 Medicare services from Dr. Haque across 8 procedure codes in 2024, for 246 Medicare patients. Medicare paid $135,419 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 246 Medicare patients who saw Dr. Haque in 2024. The largest group is 75 to 84, with 108 patients. 75% of them have depression, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haque's median patient age at 76, with 61% women.

In 2024, Dr. Haque wrote 4,929 Medicare Part D claims for 301 patients. 99% of them were for generic drugs. CMS names the drug for 4,849 of them, across 42 drugs with 11 or more claims each, at $109,164 in total drug cost. In 2023, CMS named 5,054 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Haque for performance year 2024, reported through an alternative payment model (APM). Dr. Haque accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haque as offering telehealth.

Dmand AI links 1 paper to Dr. Haque in 2021. Dr. Haque's most frequent co-authors are Bienvenida S. Austria, MD, Yun Freudenberg-Hua, MD and Blaine S. Greenwald, MD.

CMS Open Payments shows 1 general payment to Dr. Haque from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $43.

Dr. Haque graduated from Sir Salimullah Medical College in 1992.

Dr. Haque is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.